Dr. Craig J Hudson is a distinguished psychiatrist, medical researcher, and entrepreneur known for his innovative approach to central nervous system (CNS) research. Trained in the University of Toronto system, Dr. Hudson has spent over 30 years pursuing CNS discoveries to develop better treatments for complex mental health challenges. He is the founder of Biosential Inc., a biotechnology company which he founded in 1999.
Born and raised in Toronto, Ontario, Canada, Craig Hudson attended University of Waterloo where he first developed an interest in research science. He earned his medical degree at the University of Toronto in 1988 and became a Fellow of the Royal College of Physicians of Canada in 1993 specializing in psychiatry.
In 1999, Craig Hudson and his wife, Susan Hudson, noticed that there was a gap in the medical research marketplace. Observing friends and colleagues struggling to launch medical businesses—many of which failed due to a lack of funding—they saw an opportunity to innovate. Dr. Hudson conceived the idea of developing a natural product with proven clinical benefits that could enter the market quickly. This approach would help Craig and Susan generate cash flow and avoid the prolonged gap between initial funding and the extended timeline often required for clinical market regulatory approvals.
With this strategy in mind, the Hudsons decided to venture out independently, focusing on products with clear, scientifically backed benefits and rapid market access. This dual emphasis on science and speed became the foundation of Biosential Inc.’s success, positioning the company as a leader in merging rigorous research with sustainable profitability.
From the outset, the goal of Biosential Inc. was to reimagine consumer health products by blending robust scientific investigation with innovative, market-savvy approaches. Despite the challenges—both at the start and in the years that followed—Dr. Hudson and Susan were driven by their conviction that their work was both necessary and impactful.
Biosential’s mission has always been rooted in advancing scientific discovery while supporting other practitioners in the field. True to this ethos, the company has conducted extensive studies and clinical trials. One area of focus has been the protein source tryptophan and its efficacy as a sleep aid. Additionally, Dr. Hudson has explored the role of microsatellite polymorphism in schizophrenia and other neurodevelopmental disorders, contributing valuable insights to these complex fields.
This commitment to science and innovation has established Biosential as a pioneering force, bridging the gap between rigorous research and real-world applications in consumer health.
Craig Hudson’s net worth is currently unknown.
David Birkenshaw is an accomplished professional in the mining industry and an active investor in the Toronto business c...
Read MoreCole Diamond is a Canadian serial entrepreneur and early-stage investor known for his success in building start-up compa...
Read MoreShawn Achor is an author and speaker involved in the positive psychology movement. He discusses the connection between h...
Read MoreMichael Hyatt is a Toronto-based entrepreneur, investor, and philanthropist. A former Canadian Top 40 Under 40, Michael ...
Read More